PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
34.15%
Revenue growth above 1.5x MRVL's 5.79%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
41.62%
Gross profit growth above 1.5x MRVL's 5.78%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
53.19%
EBIT growth above 1.5x MRVL's 28.88%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
53.19%
Operating income growth above 1.5x MRVL's 28.88%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
49.37%
Net income growth above 1.5x MRVL's 20.82%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
52.00%
EPS growth above 1.5x MRVL's 20.83%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
48.00%
Diluted EPS growth above 1.5x MRVL's 20.83%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.20%
Share reduction while MRVL is at 0.20%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Reduced diluted shares while MRVL is at 0.20%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.80%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
15.50%
OCF growth under 50% of MRVL's 347.11%. Michael Burry might suspect questionable revenue recognition or rising costs.
16.42%
FCF growth under 50% of MRVL's 37258.33%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
1518.55%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
462.25%
5Y revenue/share CAGR above 1.5x MRVL's 27.06%. David Dodd would look for consistent product or market expansions fueling outperformance.
284.03%
3Y revenue/share CAGR above 1.5x MRVL's 46.99%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4152.63%
10Y OCF/share CAGR above 1.5x MRVL's 61.90%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1386.02%
5Y OCF/share CAGR above 1.5x MRVL's 28.06%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
474.19%
3Y OCF/share CAGR above 1.5x MRVL's 51.81%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
7228.78%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
641.72%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
592.96%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
624.82%
10Y equity/share CAGR above 1.5x MRVL's 94.66%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
246.53%
5Y equity/share CAGR above 1.5x MRVL's 53.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
117.29%
3Y equity/share CAGR above 1.5x MRVL's 41.14%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
110.43%
10Y dividend/share CAGR above 1.5x MRVL's 0.09%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
5.21%
5Y dividend/share CAGR above 1.5x MRVL's 0.19%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
-1.86%
Negative near-term dividend growth while MRVL invests at 0.09%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.59%
AR growth well above MRVL's 0.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.65%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
9.27%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
21.20%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
0.67%
Debt growth far above MRVL's 0.79%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
12.45%
R&D growth drastically higher vs. MRVL's 1.33%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.77%
SG&A growth well above MRVL's 1.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.